Results 41 to 50 of about 5,941 (171)

Epigenetic Landscape of Kaposi's Sarcoma-Associated Herpesvirus Genome in Classic Kaposi's Sarcoma Tissues. [PDF]

open access: yesPLoS Pathogens, 2017
Kaposi's sarcoma-associated herpesvirus (KSHV) is etiologically related to Kaposi's sarcoma (KS), primary effusion lymphoma (PEL) and multicentric Castleman's disease (MCD).
Rui Sun   +6 more
doaj   +1 more source

Modulation of Autophagy-Like Processes by Tumor Viruses [PDF]

open access: yes, 2014
Autophagy is an intracellular degradation pathway for long-lived proteins and organelles. This process is activated above basal levels upon cell intrinsic or environmental stress and dysregulation of autophagy has been linked to various human diseases ...
Mack, Hildegard I. D., Munger, Karl
core   +1 more source

Modulation of immune system by Kaposi’s sarcoma-associated herpesvirus:Lessons from viral evasion strategies

open access: yesFrontiers in Microbiology, 2012
Kaposi’s sarcoma-associated herpesvirus (KSHV), a member of the herpesvirus family, has evolved to establish a long-term, latent infection of cells such that while they carry the viral genome gene expression is highly restricted.
Hye-Ra eLee   +3 more
doaj   +1 more source

Productively infected murine Kaposi's sarcoma-like tumors define new animal models for studying and targeting KSHV oncogenesis and replication. [PDF]

open access: yesPLoS ONE, 2014
Kaposi's sarcoma (KS) is an AIDS-defining cancer caused by the KS-associated herpesvirus (KSHV). KS tumors are composed of KSHV-infected spindle cells of vascular origin with aberrant neovascularization and erythrocyte extravasation. KSHV genes expressed
Brittany M Ashlock   +3 more
doaj   +1 more source

Raman tweezers provide the fingerprint of cells supporting the late stages of KSHV reactivation [PDF]

open access: yes, 2009
Kaposi's sarcoma-associated herpesvirus (KSHV) has both latent and lytic phases of replication. The molecular switch that triggers a reactivation is still unclear. Cells from S phase of cell cycle provide apt conditions for an active reactivation.
Akula   +56 more
core   +1 more source

The T-Cell Immune Response against Kaposi's Sarcoma-Associated Herpesvirus

open access: yesAdvances in Virology, 2010
Kaposi's sarcoma-associated herpesvirus (KSHV) is the aetiological agent of Kaposi's sarcoma (KS), the most frequently arising malignancy in individuals with untreated HIV/AIDS.
Rebecca C. Robey   +2 more
doaj   +1 more source

Targeting the ATP-dependent formation of herpesvirus ribonucleoprotein particle assembly as an antiviral approach [PDF]

open access: yes, 2016
Human herpesviruses are responsible for a range of debilitating acute and recurrent diseases, including a number of malignancies. Current treatments are limited to targeting the herpesvirus DNA polymerases, however with emerging viral resistance and ...
Foster, R   +6 more
core   +1 more source

For the Future Studies of Kaposi’s Sarcoma-Associated Herpesvirus [PDF]

open access: yesFrontiers in Microbiology, 2012
It is 18 years since Kaposi’s sarcoma-associated virus (KSHV), also called human herpesvirus 8 (HHV-8), was found from Kaposis’ sarcoma (KS) by Chang et al. (1994). More than 8, 000 reports have been published so far and we have learned many things from this virus.
openaire   +3 more sources

Kaposi’s sarcoma in AIDS patients: a case series

open access: yesPrzegląd Dermatologiczny
Kaposi’s sarcoma is a multifocal tumor of endothelial origin associated with human herpesvirus 8 infection. Lesions typically appear as patches, plaques, or hemorrhagic nodules.
Małgorzata Dominiak   +3 more
doaj   +1 more source

Long Non-Coding RNA and Epigenetic Gene Regulation of KSHV

open access: yesViruses, 2014
Kaposi’s sarcoma-associated herpesvirus (KSHV/human herpesvirus 8) is a γ-herpesvirus linked to Kaposi’s sarcoma (KS) and two lymphoproliferative disorders, primary effusion lymphoma (PEL or body-cavity B-lymphoma [BCBL]) and a subset of Multicentric ...
Mel Campbell   +2 more
doaj   +1 more source

Home - About - Disclaimer - Privacy